This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The treatment of Boerhaave's syndrome is usually surgical. Ideally, this should be instituted within six hours of diagnosis and with stabilization of the patient: after this time, the metabolic effects and damage to the oesophagus make survival less likely.

Surgery entails draining the pleural cavity, searching for concomitant pathology at thoracotomy, e.g. tumours, oversewing the lesion, and closing the chest with an underwater seal drain. Oesophagectomy may be required for extensive stenosing lesions. Parenteral feeding or a feeding gastrostomy may be required.

Surgery has a 36% mortality, whereas medical management has a 65% mortality within 24 hours and a 100% mortality after one week.

But note, Larrieu et al. report of one case which was treated sucessfully with medical therapy (1).

Also Turut et a report the successful conservative treatment of a patient diagnosed 86 hours after presenting with chest pain (2).

  • the authors suggest the main criterion of prognosis is not only the free interval between diagnosis and treatment but the clinical form. they suggest conservative management, including intrathoracic lavage and close monitorng in patients with late presentation with a distal esophageal tear

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.